Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Statement re Possible Offer

9 Oct 2015 14:18

RNS Number : 8442B
Al Noor Hospitals Group PLC
09 October 2015
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE

 

FOR IMMEDIATE RELEASE

October 9th, 2015

 

The Board of Al Noor Hospitals Group Plc (the "Company") notes the recent media speculation in relation to the Company and confirms that it has received an approach from NMC Health Plc ("NMC") regarding a possible offer.

 

In accordance with Rule 2.6(a) of the Code, NMC is required, by not later than 5.00 p.m. on November 6th, 2015, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Code.

 

A copy of this announcement will be available at www.alnoorhospital.com/investors.

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Enquiries

Rothschild (lead financial adviser and co-sponsor)

Robert LeitãoHedley Goldberg

 

Tel: +44 207 280 5000

Goldman Sachs International (co-financial adviser and corporate broker)

Ben ThorpeNimesh Khiroya

 

Tel: +44 207 774 1000

Jefferies (corporate broker and co-sponsor)

Paul Nicholls

Henry Elphick

 

 

Tel: +44 207 029 8000

This announcement has been issued by and is the sole responsibility of the Company.

N M Rothschild & Sons Limited ("Rothschild"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Rothschild or for providing advice in relation to the matters set out in this announcement.

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Goldman Sachs International nor for providing advice in relation to the matters in this announcement. Neither Goldman Sachs International nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs International in connection with this announcement, any statement contained herein or otherwise.

Jefferies International Limited ("Jefferies"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Jefferies or for providing advice in relation to the matters set out in this announcement. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so would breach any applicable law.

 

Disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror

and Dealing Disclosures must also be made by the offeree company, by any offeror and by

any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening

Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure

Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of

the number of relevant securities in issue, when the offer period commenced and when any

offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44

(0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening

Position Disclosure or a Dealing Disclosure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDLLFLVISLAIIE
Date   Source Headline
2nd Apr 20192:15 pmRNSExercise of Share Options
15th Mar 20192:49 pmRNSGrant of Options
15th Mar 20192:47 pmRNSGrant of Options
14th Mar 20192:21 pmRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSFinancial Report: Full year ended 31 Dec 2018
5th Mar 20197:00 amRNSUpdate on KSA Joint Venture
20th Feb 20191:43 pmRNSNotice of Full Year Results
8th Feb 201912:00 pmRNSBoard Change
4th Feb 201912:00 pmRNSExercise of options
24th Jan 20191:44 pmRNSTR-1 Notification of Major Holdings
17th Jan 20193:33 pmRNSExercise of Options
27th Dec 201811:01 amRNSDirector/PDMR Shareholding
20th Dec 201812:53 pmRNSReplacement Director/PDMR Shareholding
20th Dec 201810:15 amRNSDirector/PDMR Shareholding
19th Dec 20183:59 pmRNSDirector/PDMR Shareholding
10th Dec 201811:05 amRNSPurchase of Shares
10th Dec 201811:05 amRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSTrading Update
31st Oct 201812:25 pmRNSPurchase of Shares
24th Oct 20182:34 pmRNSDirector/PDMR Shareholding
24th Oct 20182:34 pmRNSBlock listing six monthly return
24th Oct 20182:34 pmRNSBlock listing six monthly return
22nd Oct 20187:00 amRNSCapital Markets Day & Positively Revised Guidance
29th Aug 201812:47 pmRNSAmended - Purchase of Shares
29th Aug 201811:55 amRNSPurchase of Shares
28th Aug 20187:00 amRNSRegarding Press Speculation
22nd Aug 20183:30 pmRNSSale of Shares
20th Aug 20187:02 amRNSBusiness Update
20th Aug 20187:00 amRNSHalf-year Report - Part 2
20th Aug 20187:00 amRNSHalf-year Report - Part 1
11th Jul 201812:47 pmRNSNotice of Half Year Results
28th Jun 20184:32 pmRNSResult of AGM
27th Jun 20189:29 amRNSTotal Voting Rights
25th Jun 20182:24 pmRNSNotification of Major holding
12th Jun 20183:37 pmRNSExercise of options and sale of shares
12th Jun 20183:35 pmRNSExercise of share options
11th Jun 20187:00 amRNSAgreement
25th May 201810:56 amRNSAGM and Dividend Timetable
21st May 20183:05 pmRNS2017 Annual Report published
10th May 201810:48 amRNSHolding(s) in Company
3rd May 20185:19 pmRNSDirector/PDMR Shareholding
3rd May 20185:16 pmRNSHolding(s) in Company
2nd May 20185:09 pmRNSDirector/PDMR Shareholding
30th Apr 20184:10 pmRNSTotal Voting Rights
30th Apr 20182:12 pmRNSBlock listing Interim Review
30th Apr 20182:12 pmRNSBlock listing Interim Review
26th Apr 201812:59 pmRNSHolding(s) in Company
23rd Apr 20186:25 pmRNSPlacement of USD 450 million bonds
23rd Apr 20187:00 amRNSOffering of USD 450 million bonds
29th Mar 20183:18 pmRNSSale of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.